Rev-erbs agonist SR9009 alleviates ischemia-reperfusion injury by heightening endogenous cardioprotection at onset of type-2 diabetes in rats: Down-regulating ferritinophagy/ferroptosis signaling
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy October 2022 154 - Subject
- Language
- ISSN
- 0753-3322